Darrell Maxwell

Title: The Innovations of Darrell Maxwell

Introduction

Darrell Maxwell is an accomplished inventor based in Washington, DC. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the mGluR5 receptor. His work has the potential to impact the treatment of various central nervous system disorders.

Latest Patents

Maxwell holds a patent for "Oxazolidinones as modulators of mGluR5." This patent relates to compounds of formula I, including their salts, as well as compositions and methods of using these compounds. The compounds serve as ligands, agonists, and partial agonists for the mGluR5 receptor, which may be useful in treating a range of disorders affecting the central nervous system. He has 1 patent to his name.

Career Highlights

Darrell Maxwell is currently employed at Bristol-Myers Squibb Company, where he continues to innovate and develop new therapeutic solutions. His work at this leading pharmaceutical company allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Maxwell has worked alongside notable colleagues, including Andrew P. Degnan and Matthew D. Hill. These collaborations have fostered an environment of innovation and have led to advancements in their shared research interests.

Conclusion

Darrell Maxwell's contributions to medicinal chemistry and his innovative patent on mGluR5 modulators highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for new treatments for central nervous system disorders.